PurpleLab

PurpleLab operates a multi-product B2B model built on proprietary healthcare data assets. It creates value by structuring, enriching and linking patient- and provider-level healthcare data, then packaging that data into software workflows for research, commercial intelligence, audience creation, activation and measurement. Revenue is generated from recurring platform access, enterprise data licensing, campaign-related activation and measurement, and consulting support that helps clients implement and operationalise the platform.

PurpleLab is a private US healthcare data and analytics company that sells proprietary real-world healthcare datasets, no-code analytics software and healthcare-specific advertising and measurement tools. Its platform combines structured medical and pharmacy claims, provider data and enriched datasets to support research, cohort building, patient journey analysis, audience creation and campaign measurement.

The company serves life sciences organisations, healthcare payers, providers, pharmaceutical advertisers, agencies and analytics teams. It makes money through enterprise software subscriptions, licensing and delivery of proprietary data assets, advertising activation and measurement fees, and consulting services tied to implementation and analytics workflows. The 2025 acquisition of KAID Health indicates an expansion into AI-powered clinical analytics using unstructured data alongside its core structured claims assets.